Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials

Affiches Apr 7, 2025

Immunologie

Séquençage

April 7, 2025

Matt Clutter

Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials

Études de cas

Jun 15, 2026

Improved whole transcriptome sequencing for challenging clinical samples: A streamlined alternative to targeted RNA-seq

Affiches

Apr 21, 2026

High quality whole transcriptome RNA-sequencing from challenging clinical samples

Poster: analytical validation of high-resolution ctDNA profiling with TSO500 v2.0.

Affiches

Apr 20, 2026

Scaling Liquid Biopsy Biomarker Discovery: multi-center, Analytical Validation of high resolution ctDNA Profiling Using TSO500 ctDNA v2.0 on NovaSeq X Plus

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials

Featured Resources

Improved whole transcriptome sequencing for challenging clinical samples: A streamlined alternative to targeted RNA-seq

High quality whole transcriptome RNA-sequencing from challenging clinical samples

Scaling Liquid Biopsy Biomarker Discovery: multi-center, Analytical Validation of high resolution ctDNA Profiling Using TSO500 ctDNA v2.0 on NovaSeq X Plus

One global CRO for your whole therapeutic development journey